LASA
Lasa Supergenerics Limited
Pharmaceutical company with a single factory in Ratnagiri, Maharashtra
Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals
lasalabs.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-12
Stock price
₹5.16
Market cap
26 Cr
Stock P/E
Loss (TTM EPS ₹-3.30)
P/B
0.46
ROE (FY26)
-68.7%
ROCE (FY26)
-57.6%
Operating margin (FY26)
-136.9%
Debt / equity (FY26)
0.20
OCF / EBITDA (FY25)
-45.1%
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Lasa Supergenerics makes active pharmaceutical ingredients (APIs), mainly for veterinary use, at a single factory in Ratnagiri district, Maharashtra; production operations were suspended after a fire at the plant in May 2025.
Company snapshot
118thBy market cap
Ranked among 119 companies in Pharmaceuticals.
What we see
Positives
- ✓Debt-to-equity of 0.20x — the company is largely funded by its own money, not borrowed funds.
Concerns
- ✗Net margin is negative — the company is spending more than it earns right now.
2 more signals from the filings.Sign in free to see them all
Statement tables · Standalone
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Standalone only
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 24 Cr | 27 Cr | 23 Cr | 31 Cr | 39 Cr | 33 Cr | 39 Cr | 20 Cr | 3 Cr | 2 Cr | -0.13 Cr | 1 Cr |
| Operating expenses (approx.) | 23 Cr | 26 Cr | 27 Cr | 29 Cr | 39 Cr | 32 Cr | 36 Cr | 21 Cr | 7 Cr | 3 Cr | 2 Cr | 3 Cr |
| EBITDA | 1 Cr | 1 Cr | -4 Cr | 2 Cr | 0.79 Cr | 0.79 Cr | 3 Cr | -0.50 Cr | -4 Cr | -0.75 Cr | -3 Cr | -1 Cr |
| OPM % | 4.3% | 3.9% | -17.4% | 5.8% | 2.0% | 2.4% | 8.7% | -2.5% | -130.6% | -34.0% | 1963.0% | -113.4% |
| Other income | 0.08 Cr | 0.0036 Cr | 0.0079 Cr | 0.0047 Cr | 2 Cr | 0.14 Cr | 2 Cr | 0.13 Cr | 0.0070 Cr | 0.02 Cr | 0.04 Cr | 0.10 Cr |
| Interest | 0.56 Cr | 0.44 Cr | 0.56 Cr | 0.87 Cr | 1 Cr | 0.47 Cr | 0.11 Cr | 0.03 Cr | 0.12 Cr | 0.11 Cr | 0.13 Cr | 0.14 Cr |
| Depreciation | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 4 Cr | 2 Cr | 2 Cr | 2 Cr | 1 Cr | 2 Cr |
| Profit before tax | -2 Cr | -2 Cr | -16 Cr | -2 Cr | -1 Cr | 6 Cr | -22 Cr | -23 Cr | -6 Cr | -2 Cr | -4 Cr | -3 Cr |
| Tax % | 98.9% | 29.4% | 4.2% | -46.6% | -145.9% | 7.0% | 35.4% | 6.3% | -10.1% | -5.9% | -4.7% | -3.0% |
| Net profit | -0.02 Cr | -1 Cr | -15 Cr | -3 Cr | -3 Cr | 5 Cr | -14 Cr | -21 Cr | -6 Cr | -3 Cr | -4 Cr | -4 Cr |
| EPS (₹) | ₹0.00 | ₹-0.29 | ₹-3.05 | ₹-0.55 | ₹-0.64 | ₹1.10 | ₹-2.85 | ₹-4.22 | ₹-1.25 | ₹-0.51 | ₹-0.83 | ₹-0.71 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 218 Cr | 246 Cr | 170 Cr | 167 Cr | 202 Cr | 137 Cr | 130 Cr | 104 Cr | 142 Cr | 25 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 173 Cr | 205 Cr | 158 Cr | 137 Cr | 155 Cr | 121 Cr | 136 Cr | 102 Cr | 136 Cr | 54 Cr | Sign in free for the trailing twelve months |
| EBITDA | 46 Cr | 41 Cr | 11 Cr | 30 Cr | 47 Cr | 16 Cr | -7 Cr | 2 Cr | 6 Cr | -28 Cr | Sign in free for the trailing twelve months |
| OPM % | 20.9% | 16.8% | 6.6% | 17.9% | 23.3% | 11.4% | -5.1% | 2.1% | 4.4% | -113.0% | Sign in free for the trailing twelve months |
| Other income | 2 Cr | 3 Cr | 4 Cr | 0.23 Cr | 0.06 Cr | 0.06 Cr | 2 Cr | 0.10 Cr | 5 Cr | 0.20 Cr | Sign in free for the trailing twelve months |
| Interest | 12 Cr | 11 Cr | 12 Cr | 8 Cr | 2 Cr | 0.04 Cr | 4 Cr | 2 Cr | 3 Cr | 0.39 Cr | Sign in free for the trailing twelve months |
| Depreciation | 8 Cr | 18 Cr | 19 Cr | 17 Cr | 16 Cr | 14 Cr | 13 Cr | 11 Cr | 12 Cr | 6 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 2 Cr | 15 Cr | -17 Cr | 4 Cr | 30 Cr | -7 Cr | -42 Cr | -19 Cr | -19 Cr | -35 Cr | Sign in free for the trailing twelve months |
| Tax % | -10.3% | 19.0% | 28.0% | 16.9% | 25.1% | 21.4% | 8.7% | -13.7% | 23.9% | 1.5% | Sign in free for the trailing twelve months |
| Net profit | 2 Cr | 12 Cr | -12 Cr | 4 Cr | 23 Cr | -5 Cr | -39 Cr | -22 Cr | -15 Cr | -34 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹1.15 | ₹5.43 | ₹-5.26 | ₹1.26 | ₹5.60 | ₹-1.32 | ₹-7.71 | ₹-4.34 | ₹-2.95 | ₹-6.80 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | — | 0.0% | — | — | — | — | — | Sign in free for the trailing twelve months |
Sign in free for the trailing twelve months
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 0.05 Cr | 23 Cr | 23 Cr | 41 Cr | 41 Cr | 41 Cr | 50 Cr | 50 Cr | 50 Cr | 50 Cr |
| Reserves | 75 Cr | 94 Cr | 82 Cr | 101 Cr | 118 Cr | 108 Cr | 68 Cr | 47 Cr | 34 Cr | -0.48 Cr |
| Borrowings | 104 Cr | 90 Cr | 69 Cr | 34 Cr | — | — | — | 22 Cr | 3 Cr | 10 Cr |
| Other liabilities | 49 Cr | 79 Cr | 84 Cr | 56 Cr | 49 Cr | 51 Cr | 46 Cr | 32 Cr | 15 Cr | 7 Cr |
| Total liabilities | 228 Cr | 287 Cr | 258 Cr | 232 Cr | 208 Cr | 199 Cr | 164 Cr | 151 Cr | 102 Cr | 66 Cr |
| Fixed assets (net) | 113 Cr | 164 Cr | 156 Cr | 146 Cr | 138 Cr | 118 Cr | 88 Cr | 84 Cr | 48 Cr | 38 Cr |
| CWIP | 29 Cr | 7 Cr | 7 Cr | 0 Cr | 0 Cr | 5 Cr | 5 Cr | 3 Cr | 0.25 Cr | 0 Cr |
| Investments | 0.0010 Cr | 0.0010 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0.39 Cr | 0 Cr | 0 Cr | 0 Cr |
| Loans & advances | — | — | 0.05 Cr | 0.05 Cr | 0.05 Cr | 0.05 Cr | 0.05 Cr | 0.05 Cr | 0.05 Cr | 0.05 Cr |
| Inventories | 33 Cr | 42 Cr | 32 Cr | 26 Cr | 17 Cr | 11 Cr | 14 Cr | 19 Cr | 24 Cr | 2 Cr |
| Trade receivables | 35 Cr | 42 Cr | 29 Cr | 21 Cr | 15 Cr | 18 Cr | 2 Cr | 4 Cr | 1 Cr | 0.04 Cr |
| Cash & bank | 0.14 Cr | 0.50 Cr | 0.42 Cr | 3 Cr | 4 Cr | 11 Cr | 0.80 Cr | 0.61 Cr | 0.28 Cr | 0.29 Cr |
| Other assets | 17 Cr | 31 Cr | 35 Cr | 36 Cr | 34 Cr | 36 Cr | 53 Cr | 41 Cr | 27 Cr | 26 Cr |
| Total assets | 228 Cr | 287 Cr | 258 Cr | 232 Cr | 208 Cr | 199 Cr | 164 Cr | 151 Cr | 102 Cr | 66 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | -3 Cr | 40 Cr | 41 Cr | 14 Cr | 41 Cr | 10 Cr | -34 Cr | 2 Cr | -3 Cr | -23 Cr |
| Cash from investing | 0.38 Cr | -44 Cr | -7 Cr | -2 Cr | -4 Cr | -3 Cr | 2 Cr | -0.40 Cr | 8 Cr | 0 Cr |
| Cash from financing | 0.05 Cr | 4 Cr | -33 Cr | -10 Cr | -36 Cr | -0.04 Cr | 4 Cr | -2 Cr | -6 Cr | 0 Cr |
| Net cash flow | -3 Cr | 0.35 Cr | -0.08 Cr | 2 Cr | 1 Cr | 7 Cr | -27 Cr | -0.19 Cr | -0.33 Cr | -23 Cr |
| Free cash flow (OCF − Capex) | -5 Cr | -6 Cr | 29 Cr | 13 Cr | 35 Cr | 10 Cr | -38 Cr | 2 Cr | -3 Cr | -23 Cr |
Ratios
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 7.7% | 12.8% | -2.7% | 7.1% | 20.4% | -4.6% | -32.3% | -14.5% | -19.3% | -57.6% |
| ROE % | 3.1% | 10.5% | -11.4% | 2.6% | 14.3% | -3.6% | -32.7% | -22.5% | -17.6% | -68.7% |
| Debtor days | 58 | 62 | 62 | 45 | 27 | 49 | 7 | 13 | 4 | 1 |
| Inventory days | 86 | 89 | 137 | 111 | 62 | 47 | 46 | 88 | 82 | 35 |
| Days payable | 65 | 101 | 259 | 142 | 45 | 65 | 31 | 65 | 34 | 40 |
| Cash conversion cycle | 79 | 50 | -60 | 14 | 43 | 31 | 22 | 36 | 52 | -5 |
| OCF / EBITDA % | -6.6% | 97.6% | 366.0% | 45.5% | 87.5% | 67.1% | — | n.m. | -45.1% | — |
| OCF / EBITDA % (3 years) | — | — | 79.6% | 114.9% | 108.3% | 70.5% | 32.5% | -186.3% | n.m. | — |
| Debt / equity | 1.38 | 0.77 | 0.65 | 0.24 | 0.0090 | 0.0014 | — | 0.23 | 0.03 | 0.20 |
| Current ratio | 1.13 | 1.02 | 0.80 | 1.00 | 1.59 | 1.65 | 0.92 | 0.78 | 1.90 | 0.62 |
| Net debt / EBITDA | 2.28 | 2.17 | 6.15 | 1.07 | -0.08 | -0.71 | — | 9.91 | 0.37 | — |